Autoimmune in Menopause and Pregnancy Transitions (AMPt) Program

Listed on GrantGunner. Last checked 3 Nov 2026.

About this grant

A $50M funding program jointly funded by Wellcome Leap and Pivotal to develop solutions addressing the disproportionate autoimmune disease risk in women during hormone transitions such as pregnancy and menopause, focusing on rheumatoid arthritis, multiple sclerosis, and lupus.

Who can apply

No specific eligibility criteria provided on the page

Browse all open grants

More grants from Wellcome Leap